Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

Tauopathies are a group of neurodegenerative diseases characterized by the alteration/aggregation of TAU protein, for which there is still no effective treatment. Therefore, new pharmacological targets are being sought, such as elements of the endocannabinoid system (ECS). We analysed the occurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Galán-Ganga, M., Rodríguez-Cueto, C., Merchán-Rubira, J., Hernández, F., Ávila, J., Posada-Ayala, M., Lanciego, J. L., Luengo, E., Lopez, M. G., Rábano, A., Fernández-Ruiz, J., Lastres-Becker, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130522/
https://www.ncbi.nlm.nih.gov/pubmed/34001284
http://dx.doi.org/10.1186/s40478-021-01196-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130522/
https://www.ncbi.nlm.nih.gov/pubmed/34001284
http://dx.doi.org/10.1186/s40478-021-01196-5

Ejemplares similares